Collaboration between leading AI-enabled oncology corporations helps provide the best arsenal available for advanced cancer patients NEW YORK–(BUSINESS WIRE)–Today, xCures announced their collaboration with Massive Bio Inc. This partnership ensures that advanced cancer patients and their physicians have access to the best treatment options available. Massive Bio is a leader… Read more »

xCures has helped 1000+ advanced cancer patients and their oncologists with treatment options and recently enabled direct access to the platform through xINFORM Oakland, June 23rd, 2021 (PRNewswire) – xCures Inc., the leader in the patient-centric use of artificial intelligence (AI) and predictive modeling, announced today that it has raised… Read more »

Today, xCures enabled early access to xINFORM, an A.I.-powered platform for advanced cancer patients to identify personalized treatment options to discuss with their doctors. xINFORM is available at no charge. Patients participate with their data and receive treatment options that combine the leading thinking in precision medicine, patient preferences, and… Read more »